Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Cell · 2024-09 · 187 (18) · 4981-4995.e14
DOI: 10.1016/j.cell.2024.06.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-09. Verfasst von Lawrence T Wang und 36 weiteren Autor:innen. Beteiligte Einrichtung: Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville,…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Plasmodium falciparum, Malaria, Falciparum, Malaria Vaccines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute of Allergy and Infectious Diseases Division of Intramural Research, USAID.
Abstract (Originalsprache)
Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is the most advanced blood-stage malaria vaccine candidate and is being evaluated for efficacy in endemic regions, emphasizing the need to study the underlying antibody response to RH5 during natural infection, which could augment or counteract responses to vaccination. Here, we found that RH5-reactive B cells were rare, and circulating immunoglobulin G (IgG) responses to RH5 were short-lived in malaria-exposed Malian individuals, despite repeated infections over multiple years. RH5-specific monoclonal antibodies isolated from eight malaria-exposed individuals mostly targeted non-neutralizing epitopes, in contrast to antibodies isolated from five RH5-vaccinated, malaria-naive UK individuals. However, MAD8-151 and MAD8-502, isolated from two malaria-exposed Malian individuals, were among the most potent neutralizers out of 186 antibodies from both cohorts and targeted the same epitopes as the most potent vaccine-induced antibodies. These results suggest that natural malaria infection may boost RH5-vaccine-induced responses and provide a clear strategy for the development of next-generation RH5 vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA; Vaccine Research Center, National Institute of Allergy…
- Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
- Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3Q…
- Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
- Wellcome Sanger Institute, Cambridge CB10 1SA, UK.
- Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, Heslington, York YO10 5DD, UK.
Förderung
- Wellcome Trust
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- USAID
- U.S. Department of Health and Human Services
- Vaccine Research Center
- Silver Family Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Wang, L. T., Cooper, A. J. R., Farrell, B., Miura, K., Diouf, A., Müller-Sienerth, N., Crosnier, C., Purser, L., Kirtley, P. J., Maciuszek, M., Barrett, J. R., McHugh, K., Ogwang, R., Tucker, C., Li, S., Doumbo, S., Doumtabe, D., Pyo, C. W., Skinner, J., …, & Tan, J. (2024). Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell, 187(18), 4981-4995.e14. https://doi.org/10.1016/j.cell.2024.06.037
Vancouver
Wang LT, Cooper AJR, Farrell B, Miura K, Diouf A, Müller-Sienerth N, et al. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell. 2024;187(18):4981-4995.e14. doi:10.1016/j.cell.2024.06.037
BibTeX
@article{Wang2024,
author = {Wang, Lawrence T and Cooper, Andrew J R and Farrell, Brendan and Miura, Kazutoyo and Diouf, Ababacar and Müller-Sienerth, Nicole and Crosnier, Cécile and Purser, Lauren and Kirtley, Payton J and Maciuszek, Maciej and Barrett, Jordan R and McHugh, Kirsty and Ogwang, Rodney and Tucker, Courtney and Li, Shanping and Doumbo, Safiatou and Doumtabe, Didier and Pyo, Chul-Woo and Skinner, Jeff and Nielsen, Carolyn M and Silk, Sarah E and Kayentao, Kassoum and Ongoiba, Aissata and Zhao, Ming and Nguyen, Doan C and Lee, F Eun-Hyung and Minassian, Angela M and Geraghty, Daniel E and Traore, Boubacar and Seder, Robert A and Wilder, Brandon K and Crompton, Peter D and Wright, Gavin J and Long, Carole A and Draper, Simon J and Higgins, Matthew K and Tan, Joshua},
title = {Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5},
journal = {Cell},
year = {2024},
volume = {187},
number = {18},
pages = {4981--4995.e14},
doi = {10.1016/j.cell.2024.06.037}
}
EUVIMED